Abstract
NF-κBs are a family of transcription factors that control a number of essential cellular functions including immune responses, cell proliferation and antiapoptosis. NF-κB activities are tightly regulated through upstream signaling molecules and downstream feedback loops. In this review, structural discoveries in the NF-κB pathway are presented. With the structure information, the following questions may be addressed: (1) How do NF-κBs activate their target genes? (2) How do IκBs inhibit NF-κB activities in the steady state? (3) How do upstream signaling molecules activate the NF-κB pathway? and (4) How do the feedback loops shut down the NF-κB pathway to avoid constitutive NF-κB activation?
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Greten FR, Karin M . The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Lett 2004; 206:193–199.
Hayden MS, Ghosh S . Signaling to NF-kappaB. Genes Dev 2004; 18:2195–2224.
Sen R, Baltimore D . Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46:705–716.
Gilmore TD, Temin HM . Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell 1986; 44:791–800.
Steward R, Zusman SB, Huang LH, Schedl P . The dorsal protein is distributed in a gradient in early Drosophila embryos. Cell 1988; 55:487–495.
Steward R . Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel. Science 1987; 238:692–694.
Ghosh S, Gifford AM, Riviere LR, et al. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell 1990; 62:1019–1029.
Kieran M, Blank V, Logeat F, et al. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell 1990; 62:1007–1018.
Gilmore TD . Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006; 25:6680–6684.
Scheidereit C . IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 2006; 25:6685–6705.
Mercurio F, Zhu H, Murray BW, et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997; 278:860–866.
Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M . The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997; 91:243–252.
DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M . A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997; 388:548–554.
Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV . IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997; 278:866–869.
Yamaoka S, Courtois G, Bessia C, et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998; 93:1231–1240.
Poyet JL, Srinivasula SM, Lin JH, et al. Activation of the Ikappa B kinases by RIP via IKKgamma /NEMO-mediated oligomerization. J Biol Chem 2000; 275:37966–37977.
Li ZW, Chu W, Hu Y, et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 1999; 189:1839–1845.
Tanaka M, Fuentes ME, Yamaguchi K, et al. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 1999; 10:421–429.
Senftleben U, Cao Y, Xiao G, et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001; 293:1495–1499.
Hu Y, Baud V, Delhase M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 1999; 284:316–320.
Chen ZJ . Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 2005; 7:758–765.
Mahoney DJ, Cheung HH, Mrad RL, et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA 2008; 105:11778–11783.
Vince JE, Pantaki D, Feltham R, et al. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J Biol Chem 2009; 284:35906–35915.
Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD . Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 2006; 8:398–406.
Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ . Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006; 22:245–257.
Zarnegar BJ, Wang Y, Mahoney DJ, et al. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol 2008; 9:1371–1378.
Vince JE, Wong WW, Khan N, et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007; 131:682–693.
Varfolomeev E, Blankenship JW, Wayson SM, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007; 131:669–681.
Petersen SL, Wang L, Yalcin-Chin A, et al. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 2007; 12:445–456.
Vallabhapurapu S, Matsuzawa A, Zhang W, et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 2008; 9:1364–1370.
Wu H, Tschopp J, Lin SC . Smac mimetics and TNFalpha: a dangerous liaison? Cell 2007; 131:655–658.
Biswas DK, Shi Q, Baily S, et al. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 2004; 101:10137–10142.
Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118:285–296.
Davis RE, Brown KD, Siebenlist U, Staudt LM . Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001; 194:1861–1874.
Zhou Y, Eppenberger-Castori S, Marx C, et al. Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers. Int J Biochem Cell Biol 2005; 37:1130–1144.
Andresen L, Jorgensen VL, Perner A, et al. Activation of nuclear factor {kappa}B in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 2005; 54:503–509.
Shukla S, Maclennan GT, Marengo SR, Resnick MI, Gupta S . Constitutive activation of PI3K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 2005; 64:224–239.
Krappmann D, Emmerich F, Kordes U, et al. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 1999; 18:943–953.
Aupperle K, Bennett B, Han Z, et al. NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes. J Immunol 2001; 166:2705–2711.
Ludwig L, Kessler H, Wagner M, et al. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation. Cancer Res 2001; 61:4526–4535.
Tamatani T, Azuma M, Aota K, et al. Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells. Cancer Lett 2001; 171:165–172.
Baeuerle PA, Henkel T . Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12:141–179.
Blank V, Kourilsky P, Israel A . NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci 1992; 17:135–140.
Chen FE, Ghosh G . Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene 1999; 18:6845–6852.
Ghosh G, van Duyne G, Ghosh S, Sigler PB . Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature 1995; 373:303–310.
Muller CW, Rey FA, Sodeoka M, Verdine GL, Harrison SC . Structure of the NF-kappa B p50 homodimer bound to DNA. Nature 1995; 373:311–317.
Chen FE, Huang DB, Chen YQ, Ghosh G . Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature 1998; 391:410–413.
Chen YQ, Ghosh S, Ghosh G . A novel DNA recognition mode by the NF-kappa B p65 homodimer. Nat Struct Biol 1998; 5:67–73.
Cramer P, Larson CJ, Verdine GL, Muller CW . Structure of the human NF-kappaB p52 homodimer-DNA complex at 2.1 A resolution. EMBO J 1997; 16:7078–7090.
Huxford T, Ghosh G . A structural guide to proteins of the NF-kappaB signaling module. Cold Spring Harb Perspect Biol 2009; 1:a000075.
Michel F, Soler-Lopez M, Petosa C, et al. Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family. EMBO J 2001; 20:6180–6190.
Huxford T, Huang DB, Malek S, Ghosh G . The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 1998; 95:759–770.
Jacobs MD, Harrison SC . Structure of an IkappaBalpha/NF-kappaB complex. Cell 1998; 95:749–758.
Malek S, Huang DB, Huxford T, Ghosh S, Ghosh G . X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex. J Biol Chem 2003; 278:23094–23100.
Rothwarf DM, Zandi E, Natoli G, Karin M . IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998; 395:297–300.
Mercurio F, Murray BW, Shevchenko A, et al. IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol 1999; 19:1526–1538.
Rushe M, Silvian L, Bixler S, et al. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure 2008; 16:798–808.
May MJ, D'Acquisto F, Madge LA, et al. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000; 289:1550–1554.
Lo YC, Maddineni U, Chung JY, et al. High-affinity interaction between IKKbeta and NEMO. Biochemistry 2008; 47:3109–3116.
Bagneris C, Ageichik AV, Cronin N, et al. Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. Mol Cell 2008; 30:620–631.
Lo YC, Lin SC, Rospigliosi CC, et al. Structural Basis for Recognition of Diubiquitins by NEMO. Mol Cell 2009; 33:602–615.
Yoshikawa A, Sato Y, Yamashita M, et al. Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin. FEBS Lett 2009; 583:3317–3322.
Cordier F, Grubisha O, Traincard F, et al. The zinc finger of NEMO is a functional ubiquitin-binding domain. J Biol Chem 2009; 284:2902–2907.
Cordier F, Vinolo E, Veron M, Delepierre M, Agou F . Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation. J Mol Biol 2008; 377:1419–1432.
Banner DW, D'Arcy A, Janes W, et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 1993; 73:431–445.
Park YC, Burkitt V, Villa AR, Tong L, Wu H . Structural basis for self-association and receptor recognition of human TRAF2. Nature 1999; 398:533–538.
Ye H, Park YC, Kreishman M, Kieff E, Wu H . The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 1999; 4:321–330.
Park YC, Ye H, Hsia C, et al. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 2000; 101:777–787.
Ye H, Arron JR, Lamothe B, et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 2002; 418:443–447.
Ye H, Cirilli M, Wu H . The use of construct variation and diffraction data analysis in the crystallization of the TRAF domain of human tumor necrosis factor receptor associated factor 6. Acta Crystallogr D Biol Crystallogr 2002; 58:1886–1888.
Ye H, Wu H . Thermodynamic characterization of the interaction between TRAF2 and receptor peptides by isothermal titration calorimetry. Proc Natl Acad Sci USA 2000; 97:8961–8966.
Ni CZ, Welsh K, Leo E, et al. Molecular basis for CD40 signaling mediated by TRAF3. Proc Natl Acad Sci USA 2000; 97:10395–10399.
Guasparri I, Wu H, Cesarman E . The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep 2006; 7:114–119.
Yin Q, Lin SC, Lamothe B, et al. E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol 2009; 16:658–666.
Yin Q, Lamothe B, Darnay BG, Wu H . Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2. Biochemistry 2009; 48:10558–67.
Zheng C, Kabaleeswaran V, Wang Y, Cheng G, Wu H . Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation. Mol Cell 2010; 38:101–113.
Mace PD, Smits C, Vaux DL, Silke J, Day CL . Asymmetric recruitment of cIAPs by TRAF2. J Mol Biol 2010; 400:8–15.
Varfolomeev E, Goncharov T, Fedorova AV, et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 2008; 283:24295–24299.
Lin SC, Lo YC, Wu H . Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010; 465:885–890.
Dai Y, Lawrence TS, Xu L . Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B. Am J Transl Res 2009; 1:1–15.
Lin Y, Bai L, Chen W, Xu S . The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets; 14:45–55.
Hymowitz SG, Wertz IE . A20: from ubiquitin editing to tumour suppression. Nat Rev Cancer; 10:332–341.
Krikos A, Laherty CD, Dixit VM . Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem 1992; 267:17971–17976.
Kovalenko A, Chable-Bessia C, Cantarella G, et al. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 2003; 424:801–805.
Trompouki E, Hatzivassiliou E, Tsichritzis T, et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003; 424:793–796.
Brummelkamp TR, Nijman SM, Dirac AM, Bernards R . Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003; 424:797–801.
Makarova KS, Aravind L, Koonin EV . A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem Sci 2000; 25:50–52.
Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004; 430:694–699.
Heyninck K, Beyaert R . A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci 2005; 30:1–4.
Lin SC, Chung JY, Lamothe B, et al. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J Mol Biol 2008; 376:526–540.
Komander D, Barford D . Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem J 2008; 409:77–85.
Hu M, Li P, Li M, et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002; 111:1041–1054.
Johnston SC, Riddle SM, Cohen RE, Hill CP . Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J 1999; 18:3877–3887.
Saito K, Kigawa T, Koshiba S, et al. The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma. Structure 2004; 12:1719–1728.
Komander D, Lord CJ, Scheel H, et al. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol Cell 2008; 29:451–464.
Acknowledgements
We apologize to those whose work was not included due to space limitations. The work was supported by NIH grants AI045937, AI050872 and AI079260 (to HW).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zheng, C., Yin, Q. & Wu, H. Structural studies of NF-κB signaling. Cell Res 21, 183–195 (2011). https://doi.org/10.1038/cr.2010.171
Published:
Issue date:
DOI: https://doi.org/10.1038/cr.2010.171
Keywords
This article is cited by
-
IκBα targeting promotes oxidative stress-dependent cell death
Journal of Experimental & Clinical Cancer Research (2021)
-
Long non-coding RNA NKILA regulates expression of HSP90α, NF-κB and β-catenin proteins in the MCF-7 breast cancer cell line
Molecular Biology Reports (2021)
-
A negative feedback loop involving NF-κB/TIR8 regulates IL-1β-induced epithelial- myofibroblast transdifferentiation in human tubular cells
Journal of Cell Communication and Signaling (2021)
-
Emerging roles of microRNAs in intestinal ischemia/reperfusion–induced injury: a review
Journal of Physiology and Biochemistry (2020)
-
The role of different SIRT1-mediated signaling pathways in toxic injury
Cellular & Molecular Biology Letters (2019)
